Previously treated cases tested for RR-/MDR-TB (%) in Peru
Peru: Previously treated cases tested for RR-/MDR-TB was 95.0% in 2024. ▲ Rising
Previously treated cases tested for RR-/MDR-TB in Peru, 2005–2024
Source: World Health Organization, Global Health Observatory.
Analysis
Peru recorded 95.0% for previously treated cases tested for rr-/mdr-tb in 2024.
Compared with earlier readings it is up 6.7% on the previous year and up 14.5% over ten years.
Over the whole period, previously treated cases tested for rr-/mdr-tb in Peru peaked at 100.0% in 2013 and was at its lowest, 16.0%, in 2011.
Peru ranks 66th of 180 countries on this measure, in the middle of the range.
The long-run direction has been consistently rising across the 19 years of available data.
Previously treated cases tested for RR-/MDR-TB in Peru, year by year
| Year | Value | Change |
|---|---|---|
| 2005 | 47.0% | — |
| 2006 | 21.0% | -55.3% |
| 2007 | 23.0% | +9.5% |
| 2008 | 26.0% | +13.0% |
| 2009 | 19.0% | -26.9% |
| 2011 | 16.0% | -15.8% |
| 2012 | 52.0% | +225.0% |
| 2013 | 100.0% | +92.3% |
| 2014 | 83.0% | -17.0% |
| 2015 | 87.0% | +4.8% |
| 2016 | 81.0% | -6.9% |
| 2017 | 85.0% | +4.9% |
| 2018 | 77.0% | -9.4% |
| 2019 | 60.0% | -22.1% |
| 2020 | 59.0% | -1.7% |
| 2021 | 93.0% | +57.6% |
| 2022 | 76.0% | -18.3% |
| 2023 | 89.0% | +17.1% |
| 2024 | 95.0% | +6.7% |
Peru compared with similar countries
- Peru's 95.0% is above the median for upper middle income countries, which is 92.0%, 1.0× the median. (52 countries reporting)
- Peru's 95.0% is above the median for Latin America & Caribbean, which is 85.0%, 1.1× the median. (29 countries reporting)
Biggest year-on-year movements
Years where Previously treated cases tested for RR-/MDR-TB in Peru changed far more than this series normally does. A large move can be a real event or a change in how the figure was measured — the source note below says who published it.
| Year | Change | From | To |
|---|---|---|---|
| 2012 | +225.0% | 16.0% | 52.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 27.2% | 19.0% | 47.0% | 5 |
| 2010s | 71.2% | 16.0% | 100.0% | 9 |
| 2020s | 82.4% | 59.0% | 95.0% | 5 |
Countries ranked near Peru
More health data for Peru
- Un projection of annual infant deaths, annual growth rate -1.88 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.5045 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,235 deaths per 1,000 people (2090)
- Number of infants who die before age 1 782 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 2 (2025)
- Population ages 00-04, female, annual growth rate -0.3081 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.038 units per person (2025)
- Population ages 00-04, male, annual growth rate -0.302 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is previously treated cases tested for rr-/mdr-tb in Peru?
- Previously treated cases tested for rr-/mdr-tb in Peru was 95.0% in 2024, according to World Health Organization, Global Health Observatory.
- What is the highest previously treated cases tested for rr-/mdr-tb recorded in Peru?
- The highest recorded value was 100.0% in 2013.
- What is the lowest previously treated cases tested for rr-/mdr-tb recorded in Peru?
- The lowest recorded value was 16.0% in 2011.
- How does Peru rank for previously treated cases tested for rr-/mdr-tb?
- Peru ranks 66th out of 180 countries with data for 2024.
- Is previously treated cases tested for rr-/mdr-tb rising or falling in Peru?
- Over the last ten years it is up 14.5%. The long-run trend across the full record is rising.
- Where does this Peru data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Previously treated cases tested for RR-/MDR-TB (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 19 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).